Analysis on the status of clinical blood transfusion in Luzhou Hospital of Chinese Medicine from 2013 to 2017

Objective To analyze the clinical blood transfusion data of Luzhou Hospital of Traditional Chinese Medicine from 2013 to 2017, understand the current situation of clinical blood use, and explore the scientific and rational methods of blood use. Methods Selected 3 780 cases of blood transfusion from January 2013 to December 2017 in Luzhou Hospital of Chinese Medicine, and analyzed the use of various blood components (including red blood cell, plasma, platelets, cryoprecipitate), per capita blood transfusion, the situation of blood component transfusion and blood transfusion in internal medicine departments and surgical departments. Results There was an upward trend in the use of blood transfusion(the respective growth rates were 24.40%, -2.00%, 17.70%, 0.60%), and the trend of per capita blood transfusion decreasing by five years(the respective rates of decline were 6.90%, -3.20%, -5.00%, 0.00%), the component transfusion rate was 100.00%, phenomenon of high use with red blood cell(61.59%) and plasma(17.81%), the dosage of erythrocyte suspension (61.59%) and plasma (17.81%) was higher than that of platelet (9.61%) and cryoprecipitate (5.97%), the use of blood species was relatively simple, and the amount of autologous blood transfusion was relatively low. Conclusions The clinical blood transfusion in this hospital is more reasonable, but there is still unreasonable use of blood. It is necessary to strictly grasp the indications of blood transfusion, strengthen the training of clinicians' knowledge of blood transfusion, and further improve the quality management of clinical blood transfusion. Key words: Blood transfusion; Component blood transfusion; Reasonable blood transfusion